These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26196285)

  • 1. Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats.
    Sharp JA; Hair PS; Pallera HK; Kumar PS; Mauriello CT; Nyalwidhe JO; Phelps CA; Park D; Thielens NM; Pascal SM; Chen W; Duffy DM; Lattanzio FA; Cunnion KM; Krishna NK
    PLoS One; 2015; 10(7):e0132446. PubMed ID: 26196285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
    Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
    Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide inhibitor of complement c1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential.
    Sharp JA; Whitley PH; Cunnion KM; Krishna NK
    Front Immunol; 2014; 5():406. PubMed ID: 25202312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
    Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
    Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
    Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
    Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.
    Mauriello CT; Pallera HK; Sharp JA; Woltmann JL; Qian S; Hair PS; van der Pol P; van Kooten C; Thielens NM; Lattanzio FA; Cunnion KM; Krishna NK
    Mol Immunol; 2013 Jan; 53(1-2):132-9. PubMed ID: 22906481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants.
    Hair PS; Enos AI; Krishna NK; Cunnion KM
    PLoS One; 2019; 14(12):e0226875. PubMed ID: 31891617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide inhibitor of complement C1 modulates acute intravascular hemolysis of mismatched red blood cells in rats.
    Kumar PS; Pallera HK; Hair PS; Rivera MG; Shah TA; Werner AL; Lattanzio FA; Cunnion KM; Krishna NK
    Transfusion; 2016 Aug; 56(8):2133-45. PubMed ID: 27282513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.
    Inoshita H; Matsushita M; Koide S; Kusaba G; Ishii M; Onda K; Gi MJ; Nakata M; Ohsawa I; Horikoshi S; Ohi H; Tomino Y
    J Immunol Methods; 2009 Sep; 349(1-2):9-17. PubMed ID: 19699205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibition of the classical complement pathway by C1q-binding peptides.
    Roos A; Nauta AJ; Broers D; Faber-Krol MC; Trouw LA; Drijfhout JW; Daha MR
    J Immunol; 2001 Dec; 167(12):7052-9. PubMed ID: 11739526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
    Skliris A; Happonen KE; Terpos E; Labropoulou V; Børset M; Heinegård D; Blom AM; Theocharis AD
    Eur J Immunol; 2011 Feb; 41(2):437-49. PubMed ID: 21268013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of C1q and mannan-binding lectin with viruses.
    Thielens NM; Tacnet-Delorme P; Arlaud GJ
    Immunobiology; 2002 Sep; 205(4-5):563-74. PubMed ID: 12396016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.
    Windbichler M; Echtenacher B; Hehlgans T; Jensenius JC; Schwaeble W; Männel DN
    Infect Immun; 2004 Sep; 72(9):5247-52. PubMed ID: 15322019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1.
    Hair PS; Enos AI; Krishna NK; Cunnion KM
    Front Immunol; 2018; 9():558. PubMed ID: 29632531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency.
    Roos A; Garred P; Wildenberg ME; Lynch NJ; Munoz JR; Zuiverloon TC; Bouwman LH; Schlagwein N; Fallaux van den Houten FC; Faber-Krol MC; Madsen HO; Schwaeble WJ; Matsushita M; Fujita T; Daha MR
    Eur J Immunol; 2004 Sep; 34(9):2589-98. PubMed ID: 15307191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins.
    Thiel S
    Mol Immunol; 2007 Sep; 44(16):3875-88. PubMed ID: 17768106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives on mannan-binding lectin-mediated complement activation.
    Degn SE; Thiel S; Jensenius JC
    Immunobiology; 2007; 212(4-5):301-11. PubMed ID: 17544815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.
    Li M; Ager RR; Fraser DA; Tjokro NO; Tenner AJ
    Mol Immunol; 2008 Jun; 45(11):3244-52. PubMed ID: 18400300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemolytic assay for the measurement of functional human mannose-binding lectin: a modification to avoid interference from classical pathway activation.
    Herpers BL; de Jong BA; Dekker B; Aerts PC; van Dijk H; Rijkers GT; van Velzen-Blad H
    J Immunol Methods; 2009 Mar; 343(1):61-3. PubMed ID: 19171151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.